Monkey IFN-γ ELISA antibody pair - 10-plate

SKU
CT710-10
Validated ELISA antibody pair with standard and conjugate; reagents available separately (960 determinations).
Species reactivity: rhesus macaque, cynomolgus monkey, pig-tailed macaque, barbary macaque, baboon and African green monkey.
Format
10-plate
Price
€ 625
Reactivity
Monkey
Category
ELISA
Analyte
IFN-γ
Description
Our ELISA antibody pairs are extensively validated for high assay performance using the same reagents and materials included in U-CyTech ELISA kits. These antibody pairs are optimized to ensure reliable, sensitive, and reproducible results in a wide range of ELISA applications.
The ELISA antibody pairs are available in convenient 10- or 20-plate formats, providing 960 or 1920 determinations, respectively. Each set is supplied with either 5 or 10 vials of standards and 2 or 4 vials of Streptavidin-HRP conjugate, offering flexibility for different experimental needs and throughput requirements.
Designed for ease of use and consistent performance, these ELISA reagents support accurate quantification in immunoassays. Additional ELISA plates and reagents can be purchased separately, allowing customization of your ELISA workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Nicole Lamond Variation in virulence between three representative Bordetella pertussis pertactin-negative clinical isolates mSphere 2025 10 e0031025
Clarah Jebet Roles of cytokines in modulating Trypanosoma brucei rhodesiense infection outcomes in vervet monkeys Front Parasitol 2025 4 1725651
Parul Kapil A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge mSphere 2024 9 e0064724
Tetsuro Yamamoto Molecular Events in Immune Responses to Sublingual Influenza Vaccine with Hemagglutinin Antigen and Poly(I:C) Adjuvant in Nonhuman Primates, Cynomolgus Macaques Vaccines (Basel) 2024 12
Parul Kapil Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model J Infect Dis 2024 229 376-383
Edith Walker Impact of SIV infection on mycobacterial lipid-reactive T cell responses in Bacillus Calmette-Guérin (BCG) inoculated macaques Front Immunol 2022 13 1085786
Erin Willis Effects of Chronic Viral Infection on Lymphocyte Populations in Middle-aged Baboons (Papio anubis) Comp Med 2021 71 177-187
Weidong Zhang Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models J Investig Med 2018 66 1124-1132
Omkar Chaudhary Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration PLoS Pathog 2018 14 e1007268
Shihui Sun Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application Crit Care Med 2018 46 e419-e425